Literature DB >> 7308288

F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

J M Austyn, S Gordon.   

Abstract

A hybridoma clone which secretes a macrophage (M phi)-specific monoclonal antibody, F4/80, was produced by fusing spleen cells from a rat hyperimmunized with cultured thioglycollate-induced mouse peritoneal M phi with a mouse myeloma, NS1. Binding of antibody to primary cells and cell lines was detected by radioimmune indirect binding assay, autoradiography or fluorescence-activated cell sorter analysis. F4/80 binds to mouse M phi from the peritoneal cavity or other sources, blood monocytes, M phi derived from bone marrow precursors in culture and M phi-like cell lines, but not to other cells, including polymorphonuclear leukocytes, lymphocytes or fibroblasts. F4/80 does not bind to M phi via Fc receptors, is not cytotoxic and is of the rat IgG2b subclass. Since F4/80 binds to all M phi defined by adherence, morphology and immune phagocytosis, it provides a new marker to define the M phi in the mouse. Large differences in expression of antigen F4/80 were found, depending on intraperitoneal stimulation, time in culture and stage of maturation. Immunoprecipitation experiments demonstrated that the antigen F4/80 is part of a component of Mr 160000 which is synthesized by the M phi and, at least in part, exposed on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308288     DOI: 10.1002/eji.1830111013

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  528 in total

1.  Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration.

Authors:  A Niehaus; J Stegmüller; M Diers-Fenger; J Trotter
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration.

Authors:  W P Lynch; A H Sharpe; E Y Snyder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells.

Authors:  K E Weck; S S Kim; I V Virgin HW; S H Speck
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Kinetics and intracellular pathways required for major histocompatibility complex II-peptide loading and surface expression of a fluorescent hapten-protein conjugate in murine macrophage.

Authors:  D J Weaver; E W Voss
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

5.  Exaggerated proinflammatory and Th1 responses in the absence of gamma/delta T cells after infection with Listeria monocytogenes.

Authors:  M J Skeen; E P Rix; M M Freeman; H K Ziegler
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  Chrysalis: A New Method for High-Throughput Histo-Cytometry Analysis of Images and Movies.

Authors:  Dmitri I Kotov; Thomas Pengo; Jason S Mitchell; Matthew J Gastinger; Marc K Jenkins
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

7.  Structure and nature of macrophages participating in the wallerian degeneration of nerve fibers.

Authors:  E I Chumasov; K M Svetikova
Journal:  Neurosci Behav Physiol       Date:  1992 Sep-Oct

8.  An immune-stimulating proteoglycan from the medicinal mushroom Huaier up-regulates NF-κB and MAPK signaling via Toll-like receptor 4.

Authors:  Ailin Yang; Haitao Fan; Yanan Zhao; Xiaonan Chen; Zhixiang Zhu; Xiaojun Zha; Yunfang Zhao; Xingyun Chai; Jun Li; Pengfei Tu; Zhongdong Hu
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

9.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939

10.  The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies.

Authors:  J M Brewer; J Richmond; J Alexander
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.